Clinical Trials Browser

Phase 2 × Colonic Neoplasms × Imatinib Mesylate × Clear all

NCT02685046 2019-10-14

ImPACCT

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms

NCT00041340 2013-01-23

Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms